MOMA Therapeutics

Targeting the molecular machines of human disease

Cambridge, United States · Founded 2020 · $236.0M raised

Employees
51–200
Founded
2020
Business Model
B2B
Website
momatx.com
Total Funding
$236.0M
Last Round
$150.0M Series BMay 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

MOMA Therapeutics is a clinical-stage precision medicine company dedicated to discovering the next generation of therapies by targeting highly dynamic molecular machines — a class of enzymes that underlie human disease. The company's platform focuses on small molecule drug discovery across oncology and other areas of significant unmet need, leveraging advances in genetics and functional genomics.

Summary

MOMA Therapeutics is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $236.0M in total across 2 rounds, most recently a $150.0M Series B round in May 2022. Investors include Third Rock Ventures, Goldman Sachs and Rock Springs Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMay 2022
$150.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MOMA Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/moma-therapeutics"><img src="https://indexed.vc/api/badge/company/moma-therapeutics" alt="MOMA Therapeutics on Indexed.vc" width="260" height="76" /></a>